LenioBio GmbH

At LenioBio, we believe every person should have the opportunity to live a healthy and productive life. We have one goal: to simplify manufacturing and speed up drug delivery to the patient.

We are in the midst of an incredible journey. Our ALiCE® technology scales with the pharmaceutical R&D process: from discovery to product testing and clinical trials, and finally to GMP-grade production in the form of an end-to-end integrated production platform.

We are looking for passionate individuals that share our mindset of curiosity and commitment to add their knowledge to the team. Do you want to be part of our journey? Then please keep reading!

LenioBio is a biotech company that develops and markets a novel and proprietary protein production platform, ALiCE®, which enables protein-based therapeutics to become more accessible and affordable. LenioBio was founded in 2016 in Germany to broadly commercialize the ALiCE® platform, originally developed by DowDuPont and the Fraunhofer Institute IME.
Winning the prestigious Horizon 2020 grant in 2019 enabled our accelerated growth and our primary focus is to scale the ALiCE® technology to industrial scale.